{
    "biomarker_id": "AN6445-3",
    "biomarker_canonical_id": "AN6445",
    "condition": {
        "recommended_name": {
            "id": "DOID:9351",
            "resource": "Disease Ontology",
            "url": "https://disease-ontology.org/term/DOID:9351",
            "name": "diabetes mellitus",
            "description": "A glucose metabolism disease that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both."
        },
        "synonyms": [
            {
                "id": "DOID:9351",
                "resource": "Disease Ontology",
                "url": "https://disease-ontology.org/term/DOID:9351",
                "name": "diabetes",
                "description": ""
            }
        ],
        "id": "DOID:9351"
    },
    "biomarker_component": [
        {
            "biomarker": "increased S100A9 level",
            "assessed_biomarker_entity_id": "P06702-1",
            "assessed_entity_type": "protein",
            "assessed_biomarker_entity": {
                "recommended_name": "Protein S100-A9",
                "synonyms": [
                    {
                        "synonym": "Migration inhibitory factor-related protein 14"
                    },
                    {
                        "synonym": "MRP-14"
                    },
                    {
                        "synonym": "p14"
                    },
                    {
                        "synonym": "Calgranulin-B"
                    },
                    {
                        "synonym": "Calprotectin L1H subunit"
                    },
                    {
                        "synonym": "S100 calcium-binding protein A9"
                    },
                    {
                        "synonym": "Leukocyte L1 complex heavy chain"
                    }
                ]
            },
            "specimen": [
                {
                    "name": "blood",
                    "namespace": "UBERON",
                    "id": "0000178",
                    "url": "http://purl.obolibrary.org/obo/UBERON_0000178",
                    "loinc_code": ""
                }
            ],
            "evidence_source": [
                {
                    "id": "AN6445-3",
                    "database": "BiomarkerKB",
                    "url": "https://biomarkerkb.org/biomarker/AN6445-3"
                },
                {
                    "id": "31262951",
                    "database": "PubMed",
                    "url": "https://glygen.org/publication/PubMed/31262951",
                    "tags": [
                        "assessed_biomarker_entity",
                        " biomarker",
                        " specimen"
                    ],
                    "evidence_list": [
                        {
                            "evidence": "S100A9 and Galectin-3 are overexpressed in PCDM tumors and mediate insulin resistance. Galectin-3 and S100A9 distinguish PCDM from type 2 diabetes in subjects with new-onset diabetes."
                        }
                    ]
                }
            ]
        }
    ],
    "best_biomarker_role": [
        {
            "role": "monitoring"
        }
    ],
    "evidence_source": [
        {
            "id": "AN6445-3",
            "database": "BiomarkerKB",
            "url": "https://biomarkerkb.org/biomarker/AN6445-3"
        },
        {
            "id": "31262951",
            "database": "PubMed",
            "url": "https://glygen.org/publication/PubMed/31262951",
            "tags": [
                "best_biomarker_role",
                " condition"
            ],
            "evidence_list": [
                {
                    "evidence": "S100A9 and Galectin-3 are overexpressed in PCDM tumors and mediate insulin resistance. Galectin-3 and S100A9 distinguish PCDM from type 2 diabetes in subjects with new-onset diabetes."
                }
            ]
        }
    ],
    "crossref": [
        {
            "id": "AN6445-3",
            "database": "BiomarkerKB",
            "url": "https://biomarkerkb.org/biomarker/AN6445-3",
            "categories": [
                "Biomarkers"
            ]
        }
    ],
    "citation": [
        {
            "title": "Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic Cancer-Associated Diabetes.",
            "journal": "Diabetes care",
            "authors": "Liao WC, Huang BS, Yu YH, Yang HH, Chen PR, Huang CC, Huang HY, Wu MS, Chow LP",
            "date": "2019",
            "reference": [
                {
                    "type": "PubMed",
                    "id": "31262951",
                    "url": "https://glygen.org/publication/PubMed/31262951"
                }
            ],
            "evidence": [
                {
                    "id": "AN6445-2",
                    "database": "BiomarkerKB",
                    "url": "https://biomarkerkb.org/biomarker/AN6445-3"
                }
            ]
        }
    ],
    "section_stats": [
        {
            "table_id": "biomarker_component",
            "table_stats": [
                {
                    "field": "total",
                    "count": 1
                }
            ],
            "sort_fields": [
                "biomarker",
                "assessed_biomarker_entity_id",
                "assessed_entity_type",
                "assessed_biomarker_entity.recommended_name"
            ]
        },
        {
            "table_id": "citation",
            "table_stats": [
                {
                    "field": "total",
                    "count": 1
                }
            ],
            "sort_fields": [
                "title",
                "journal",
                "authors",
                "date"
            ]
        }
    ]
}